Gregory S Sheff, MD | |
11714 Wilson Parke Ave Ste 150, Austin, TX 78726-4061 | |
(737) 247-7200 | |
Not Available |
Full Name | Gregory S Sheff |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 25 Years |
Location | 11714 Wilson Parke Ave Ste 150, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205842564 | NPI | - | NPPES |
15262203 | Medicaid | TX | |
152622002 | Medicaid | TX | |
152622004 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | L3818 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Austin Regional Clinic Pa | 3072507789 | 349 |
News Archive
Dunking in a tub of ice water after exercise - a surprisingly popular post-workout regimen used by athletes to reduce inflammation and speed recovery - is time consuming and bone-achingly painful. New research from the University of New Hampshire finds that it may not be effective, either.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has successfully completed its tender offer for Dionex Corporation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced it has received a $1 million milestone payment from Takeda Pharmaceutical Company Limited for achieving a pre-established preclinical milestone under the companies' 2006 collaboration agreement, which also calls for additional future milestone payments and royalties on product sales.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
› Verified 8 days ago
Entity Name | Austin Regional Clinic Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821157579 PECOS PAC ID: 3072507789 Enrollment ID: O20040414000198 |
News Archive
Dunking in a tub of ice water after exercise - a surprisingly popular post-workout regimen used by athletes to reduce inflammation and speed recovery - is time consuming and bone-achingly painful. New research from the University of New Hampshire finds that it may not be effective, either.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has successfully completed its tender offer for Dionex Corporation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced it has received a $1 million milestone payment from Takeda Pharmaceutical Company Limited for achieving a pre-established preclinical milestone under the companies' 2006 collaboration agreement, which also calls for additional future milestone payments and royalties on product sales.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Gregory S Sheff, MD 6210 E Hwy 290 Ste 420, Austin, TX 78723-1142 Ph: () - | Gregory S Sheff, MD 11714 Wilson Parke Ave Ste 150, Austin, TX 78726-4061 Ph: (737) 247-7200 |
News Archive
Dunking in a tub of ice water after exercise - a surprisingly popular post-workout regimen used by athletes to reduce inflammation and speed recovery - is time consuming and bone-achingly painful. New research from the University of New Hampshire finds that it may not be effective, either.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has successfully completed its tender offer for Dionex Corporation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced it has received a $1 million milestone payment from Takeda Pharmaceutical Company Limited for achieving a pre-established preclinical milestone under the companies' 2006 collaboration agreement, which also calls for additional future milestone payments and royalties on product sales.
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.
› Verified 8 days ago
Robert Obrien, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4316 James Casey St, Bldg F200, Austin, TX 78745 Phone: 512-791-7555 | |
Jason B Holinbeck, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 38th St Ste 102, Austin, TX 78705 Phone: 512-454-4561 Fax: 512-406-7330 | |
David L. Purtle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1921 Lohmans Crossing Rd Ste 150, Austin, TX 78734 Phone: 737-717-8430 Fax: 737-717-8469 | |
Dr. Jared Kealy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6937 N Interstate 35 Ste 2, Austin, TX 78752 Phone: 877-800-5722 | |
Dr. Barbara Lynne Gray, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12505 Hymeadow Dr, Suite 2a, Austin, TX 78750 Phone: 512-219-8991 Fax: 512-219-8996 | |
Dr. Albert Edward Meisenbach Iii, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 100 West Dean Keeton, Austin, TX 78712 Phone: 512-475-8335 Fax: 512-471-0898 | |
Dr. Kanakadurga Govindaraju, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4107 Spicewood Springs Rd Ste 100, Austin, TX 78759 Phone: 512-397-3360 Fax: 512-343-7107 |